Scinderin anticorps (AA 556-703) (FITC)
Aperçu rapide pour Scinderin anticorps (AA 556-703) (FITC) (ABIN7143552)
Antigène
Voir toutes Scinderin (SCIN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 556-703
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Adseverin protein (556-703AA)
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Scinderin (SCIN)
-
Autre désignation
- SCIN
-
Sujet
-
Background: Ca(2+)-dependent actin filament-severing protein that is presumed to have a regulatory function in exocytosis by affecting the organization of the microfilament network underneath the plasma membrane. In vitro, also has barbed end capping and nucleating activities in the presence of Ca(2+). Regulates chondrocyte proliferation and differentiation. MAP kinases p38 and ERK1/2 mediate the adseverin-induced accelerated differentiation of non-hypertrophic chondrocytes (By similarity).
Aliases: Adseverin antibody, ADSV_HUMAN antibody, KIAA1905 antibody, Scin antibody, Scinderin antibody
-
UniProt
- Q9Y6U3
-
Pathways
- Regulation of Actin Filament Polymerization
Antigène
-